Clintex CTiHow CTAi fits an evolving Clinical Trials marketThe global AI in clinical trials market is estimated to be worth $ 2.04 billion in 2024 and expected to grow at compounded annual growth…Feb 61
Clintex CTiClinTex x DeSciThe scientific landscape is on the cusp of a paradigm shift. Enter Decentralised Science (DeSci), a revolutionary approach that leverages…Jan 19
Clintex CTiClinTex CTi and DeSci — The FutureClintex CTi and DeSci both work off the idea that scientific knowledge, including clinical trial intelligence, should be accessible.Jan 5Jan 5
Clintex CTiHow AI will drive success in Clinical TrialsIt takes up to 15 years and an average total R&D expenditure of $1.5–2 billion USD to bring a single new drug to market. About half of this…Jan 16, 2023Jan 16, 2023
Clintex CTiHow CTAi fits an evolving Clinical Trials marketThe global AI in clinical trials market is estimated to be worth $ 2.04 billion in 2024 and expected to grow at compounded annual growth…Feb 61
Clintex CTiClinTex x DeSciThe scientific landscape is on the cusp of a paradigm shift. Enter Decentralised Science (DeSci), a revolutionary approach that leverages…Jan 19
Clintex CTiClinTex CTi and DeSci — The FutureClintex CTi and DeSci both work off the idea that scientific knowledge, including clinical trial intelligence, should be accessible.Jan 5
Clintex CTiHow AI will drive success in Clinical TrialsIt takes up to 15 years and an average total R&D expenditure of $1.5–2 billion USD to bring a single new drug to market. About half of this…Jan 16, 2023
Clintex CTiEconomics evaluation of CANPAIN Fesability StudyIn October 2018, the UK’s National Institute for Health and Care Excellence (“NICE”) issued a call for evidence to evaluate the safety and…Jun 11
Clintex CTiClinTex 2023 RoadmapOver the past few weeks we have been meeting internally to define our strategy and goals in the runup to the new year. To this end we…Nov 28, 2022
